Oral contraceptive use and bone density in adolescent and young adult women

Delia Scholes, Laura Ichikawa, Andrea Z. LaCroix, Leslie Spangler, Jeannette M. Beasley, Susan Reed, Susan M. Ott

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: Most of the millions of oral contraceptive (OC) users are under 30 years of age and in the critical period for bone mass accrual. Study Design: This cross-sectional study of 606 women aged 14-30 years examined both OC duration and estrogen dose and their association with bone mineral density (BMD) at the hip, spine, and whole body (dual-energy X-ray absorptiometry). Results: Of 389 OC users and 217 nonusers enrolled, 50% were adolescents (14-18 years). Of OC users, 38% used "low-dose" OCs [<30 mcg ethinyl estradiol (EE)]. In adolescents, mean BMD differed by neither OC duration nor EE dose. However, 19- to 30-year-old women's mean BMD was lower with longer OC use for spine and whole body (p=.004 and p=.02, respectively) and lowest for >12 months of low-dose OCs for the hip, spine and whole body (p=.02, .003 and .002, respectively). Conclusions: Prolonged use of today's OCs, particularly <30 mcg EE, may adversely impact young adult women's bone density while using these agents.

Original languageEnglish (US)
Pages (from-to)35-40
Number of pages6
JournalContraception
Volume81
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Oral Contraceptives
Bone Density
Young Adult
Hip
Spine
Photon Absorptiometry
Estrogens
Cross-Sectional Studies
Bone and Bones

Keywords

  • Adolescents
  • Bone mineral density
  • Hormones
  • Oral contraceptives
  • Peak bone density

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Scholes, D., Ichikawa, L., LaCroix, A. Z., Spangler, L., Beasley, J. M., Reed, S., & Ott, S. M. (2010). Oral contraceptive use and bone density in adolescent and young adult women. Contraception, 81(1), 35-40. https://doi.org/10.1016/j.contraception.2009.07.001

Oral contraceptive use and bone density in adolescent and young adult women. / Scholes, Delia; Ichikawa, Laura; LaCroix, Andrea Z.; Spangler, Leslie; Beasley, Jeannette M.; Reed, Susan; Ott, Susan M.

In: Contraception, Vol. 81, No. 1, 01.2010, p. 35-40.

Research output: Contribution to journalArticle

Scholes, D, Ichikawa, L, LaCroix, AZ, Spangler, L, Beasley, JM, Reed, S & Ott, SM 2010, 'Oral contraceptive use and bone density in adolescent and young adult women', Contraception, vol. 81, no. 1, pp. 35-40. https://doi.org/10.1016/j.contraception.2009.07.001
Scholes D, Ichikawa L, LaCroix AZ, Spangler L, Beasley JM, Reed S et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception. 2010 Jan;81(1):35-40. https://doi.org/10.1016/j.contraception.2009.07.001
Scholes, Delia ; Ichikawa, Laura ; LaCroix, Andrea Z. ; Spangler, Leslie ; Beasley, Jeannette M. ; Reed, Susan ; Ott, Susan M. / Oral contraceptive use and bone density in adolescent and young adult women. In: Contraception. 2010 ; Vol. 81, No. 1. pp. 35-40.
@article{457d204da2f94e508b75e7796dad7b1e,
title = "Oral contraceptive use and bone density in adolescent and young adult women",
abstract = "Background: Most of the millions of oral contraceptive (OC) users are under 30 years of age and in the critical period for bone mass accrual. Study Design: This cross-sectional study of 606 women aged 14-30 years examined both OC duration and estrogen dose and their association with bone mineral density (BMD) at the hip, spine, and whole body (dual-energy X-ray absorptiometry). Results: Of 389 OC users and 217 nonusers enrolled, 50{\%} were adolescents (14-18 years). Of OC users, 38{\%} used {"}low-dose{"} OCs [<30 mcg ethinyl estradiol (EE)]. In adolescents, mean BMD differed by neither OC duration nor EE dose. However, 19- to 30-year-old women's mean BMD was lower with longer OC use for spine and whole body (p=.004 and p=.02, respectively) and lowest for >12 months of low-dose OCs for the hip, spine and whole body (p=.02, .003 and .002, respectively). Conclusions: Prolonged use of today's OCs, particularly <30 mcg EE, may adversely impact young adult women's bone density while using these agents.",
keywords = "Adolescents, Bone mineral density, Hormones, Oral contraceptives, Peak bone density",
author = "Delia Scholes and Laura Ichikawa and LaCroix, {Andrea Z.} and Leslie Spangler and Beasley, {Jeannette M.} and Susan Reed and Ott, {Susan M.}",
year = "2010",
month = "1",
doi = "10.1016/j.contraception.2009.07.001",
language = "English (US)",
volume = "81",
pages = "35--40",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Oral contraceptive use and bone density in adolescent and young adult women

AU - Scholes, Delia

AU - Ichikawa, Laura

AU - LaCroix, Andrea Z.

AU - Spangler, Leslie

AU - Beasley, Jeannette M.

AU - Reed, Susan

AU - Ott, Susan M.

PY - 2010/1

Y1 - 2010/1

N2 - Background: Most of the millions of oral contraceptive (OC) users are under 30 years of age and in the critical period for bone mass accrual. Study Design: This cross-sectional study of 606 women aged 14-30 years examined both OC duration and estrogen dose and their association with bone mineral density (BMD) at the hip, spine, and whole body (dual-energy X-ray absorptiometry). Results: Of 389 OC users and 217 nonusers enrolled, 50% were adolescents (14-18 years). Of OC users, 38% used "low-dose" OCs [<30 mcg ethinyl estradiol (EE)]. In adolescents, mean BMD differed by neither OC duration nor EE dose. However, 19- to 30-year-old women's mean BMD was lower with longer OC use for spine and whole body (p=.004 and p=.02, respectively) and lowest for >12 months of low-dose OCs for the hip, spine and whole body (p=.02, .003 and .002, respectively). Conclusions: Prolonged use of today's OCs, particularly <30 mcg EE, may adversely impact young adult women's bone density while using these agents.

AB - Background: Most of the millions of oral contraceptive (OC) users are under 30 years of age and in the critical period for bone mass accrual. Study Design: This cross-sectional study of 606 women aged 14-30 years examined both OC duration and estrogen dose and their association with bone mineral density (BMD) at the hip, spine, and whole body (dual-energy X-ray absorptiometry). Results: Of 389 OC users and 217 nonusers enrolled, 50% were adolescents (14-18 years). Of OC users, 38% used "low-dose" OCs [<30 mcg ethinyl estradiol (EE)]. In adolescents, mean BMD differed by neither OC duration nor EE dose. However, 19- to 30-year-old women's mean BMD was lower with longer OC use for spine and whole body (p=.004 and p=.02, respectively) and lowest for >12 months of low-dose OCs for the hip, spine and whole body (p=.02, .003 and .002, respectively). Conclusions: Prolonged use of today's OCs, particularly <30 mcg EE, may adversely impact young adult women's bone density while using these agents.

KW - Adolescents

KW - Bone mineral density

KW - Hormones

KW - Oral contraceptives

KW - Peak bone density

UR - http://www.scopus.com/inward/record.url?scp=71149097467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71149097467&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2009.07.001

DO - 10.1016/j.contraception.2009.07.001

M3 - Article

C2 - 20004271

AN - SCOPUS:71149097467

VL - 81

SP - 35

EP - 40

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 1

ER -